How does cyanide inhibit the electron transport chain?
What is the main source of ketone bodies during fasting?
What is the primary cause of hypoglycemia in alcohol intoxication?
How many molecules of NADH are produced by the TCA cycle per acetyl-CoA molecule?
What is the PRIMARY metabolic consequence of a mutation in the gene encoding NADH dehydrogenase (Complex I) that directly impacts cellular energy production?
A patient presents with symptoms of pellagra. Which biochemical pathway is primarily affected, and why?
In the TCA cycle, what is the significance of the production of NADH and FADH2, and how are these molecules utilized?
A patient presents with hemolytic anemia, and Heinz bodies are observed in red blood cells. Which enzyme deficiency is most likely?
Which molecule serves as the primary source of energy during a prolonged fast?
A newborn presents with severe metabolic acidosis and high levels of lactate. Genetic testing reveals a mutation in the PDH complex. Which condition is most likely?
Explanation: ***Inhibits complex IV*** - Cyanide binds with high affinity to the **ferric (Fe3+) iron** in the heme a3 component of **cytochrome c oxidase** (Complex IV). - This binding completely blocks the transfer of electrons to **oxygen**, halting the entire electron transport chain and oxidative phosphorylation. *Inhibits complex III (cytochrome bc1 complex)* - While inhibitors exist for Complex III (e.g., **antimycin A**), cyanide specifically targets Complex IV, not Complex III. - Complex III is involved in transferring electrons from ubiquinol to cytochrome c. *Directly inhibits ATP synthase* - Cyanide does not directly inhibit **ATP synthase**; its primary action is upstream in the electron transport chain. - ATP synthase is responsible for using the proton gradient to produce ATP, and its inhibition would be by agents like **oligomycin**. *Inhibits complex I (NADH dehydrogenase)* - Complex I is inhibited by compounds like **rotenone** or **amytal**, which block the transfer of electrons from NADH to ubiquinone. - Cyanide's mechanism of action is distinct and occurs later in the chain.
Explanation: ***Fatty acids*** - During **fasting**, the body shifts from carbohydrate to fat metabolism to produce energy. - **Fatty acids** are broken down in the liver through **beta-oxidation** to form acetyl-CoA, which is then converted into ketone bodies. *Glucose* - **Glucose** is the primary energy source in the fed state, not during fasting. - During fasting, **glucose levels** decrease, prompting the body to seek alternative fuel sources. *Amino acids* - While some **amino acids** can be converted into glucose (gluconeogenesis) or ketone bodies, they are a secondary source. - **Protein breakdown** for energy is primarily a long-term adaptation to starvation, not the main initial source of ketone bodies. *Glycogen* - **Glycogen stores** (mainly in the liver and muscles) are used during the initial hours of fasting. - Once these stores are depleted, usually within 12-24 hours, the body relies on **fatty acid oxidation** for energy, leading to ketone body production.
Explanation: ***Inhibited gluconeogenesis*** - Alcohol metabolism by **alcohol dehydrogenase** and **aldehyde dehydrogenase** generates a large amount of **NADH**, shifting the redox state of hepatocytes. - This high NADH/NAD+ ratio inhibits several key steps in the **gluconeogenesis pathway**, particularly the conversion of **lactate to pyruvate** (by lactate dehydrogenase) and **malate to oxaloacetate** (by malate dehydrogenase), leading to impaired glucose production, especially in fasting individuals. - Glycogen stores become depleted during fasting, making gluconeogenesis essential for maintaining blood glucose. *Increased lipolysis* - While alcohol can influence fat metabolism, increased lipolysis (breakdown of fats) primarily provides **fatty acids** for energy and is not the direct or primary cause of acute hypoglycemia. - Furthermore, alcohol metabolism actually tends to promote **fatty acid synthesis** and storage in the liver rather than lipolysis. *Liver damage* - **Chronic alcohol abuse** eventually leads to liver damage (e.g., cirrhosis), which can impair the liver's ability to store glycogen and perform gluconeogenesis, contributing to hypoglycemia. - However, in acute alcohol intoxication, the hypoglycemia is primarily due to the **metabolic effects** of alcohol on gluconeogenesis, not necessarily pre-existing or acute structural liver damage. *Dehydration* - Dehydration is a common consequence of alcohol consumption due to its **diuretic effect**, but it does not directly cause hypoglycemia. - Dehydration primarily affects **electrolyte balance** and **blood volume**, while hypoglycemia is a metabolic derangement of glucose regulation.
Explanation: **3** - Each turn of the **tricarboxylic acid (TCA) cycle** (Krebs cycle) directly produces **three molecules of NADH** from one molecule of acetyl-CoA. - These NADH molecules are crucial for subsequent **oxidative phosphorylation**, where they contribute to the production of ATP. *1* - Only one molecule of **FADH2** is produced per acetyl-CoA in the TCA cycle, not NADH. - The single **GTP/ATP** molecule is also produced directly within the cycle. *2* - While other stages of glucose metabolism, such as glycolysis, produce two NADH molecules, the **TCA cycle itself yields three NADH** per acetyl-CoA. - Two pyruvate molecules from one glucose molecule enter the TCA cycle (after conversion to acetyl-CoA), so considering one glucose, the cycle produces six NADH in total. *4* - The full oxidative phosphorylation pathway, including the electron transport chain, processes the NADH in stages, but the **direct production within the TCA cycle** is limited to three. - Four molecules of NADH are not directly produced in any single phase of the TCA cycle from one acetyl-CoA input.
Explanation: ***Decreased ATP synthesis*** - A mutation in **NADH dehydrogenase (Complex I)** reduces its ability to pump protons across the inner mitochondrial membrane, directly impairing the **proton gradient** essential for **ATP synthase** function. - This leads to a significant reduction in the efficiency of **oxidative phosphorylation** and, consequently, **decreased ATP production**, which is the primary metabolic defect in mitochondrial disorders. - This represents the most direct impact on cellular energy metabolism. *Normal electron transport efficiency* - Mutations in **Complex I** directly impair its function, leading to **decreased electron flow** through the electron transport chain. - Therefore, **normal electron transport efficiency** cannot occur with a dysfunctional NADH dehydrogenase. *Impaired oxidative phosphorylation* - While this is true, it describes the mechanism rather than the ultimate metabolic consequence. - Impaired OXPHOS is the process defect, whereas **decreased ATP synthesis** is the direct metabolic outcome affecting cellular function. *Increased production of reactive oxygen species* - Complex I dysfunction does lead to increased **ROS production** due to electron leakage, which contributes to oxidative damage in mitochondrial disorders. - However, when considering the **primary metabolic consequence** affecting energy production, the direct outcome is **insufficient ATP synthesis**, which causes the cellular energy deficiency characteristic of these disorders.
Explanation: ***TCA cycle due to impaired coenzyme function*** - Pellagra is caused by **niacin (vitamin B3) deficiency**, which is the precursor to **NAD+** and **NADP+** - **NAD+** is a crucial coenzyme required in **three steps of the TCA cycle** (isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, malate dehydrogenase) - The TCA cycle is the **central hub of aerobic energy metabolism**, and its impairment severely disrupts cellular ATP production - The systemic symptoms of pellagra (dermatitis, diarrhea, dementia) reflect the **widespread energy deficit** affecting highly metabolic tissues like skin, GI mucosa, and nervous system *Glycolysis due to impaired energy production* - Glycolysis does require **NAD+** in the glyceraldehyde-3-phosphate dehydrogenase step - However, glycolysis is **less dependent on oxidative metabolism** and can function anaerobically - The TCA cycle is considered **primarily affected** because it has multiple NAD+-dependent steps and is central to aerobic ATP production *Urea cycle due to disruptions in nitrogen balance* - The urea cycle is **not directly dependent on NAD+ or NADP+** as coenzymes - Pellagra does not primarily present with hyperammonemia or nitrogen balance disorders - This pathway is not the primary biochemical defect in pellagra *Pentose phosphate pathway due to reduced coenzyme availability* - This pathway produces **NADPH** (not NAD+), which is also derived from niacin via NADP+ - NADPH is vital for **reductive biosynthesis and antioxidant defense** (glutathione reduction) - While affected in niacin deficiency, the **TCA cycle impairment** better explains the severe energy crisis and systemic manifestations of pellagra
Explanation: ***They donate electrons to the electron transport chain for ATP production*** - **NADH** and **FADH2** are crucial **electron carriers** that capture high-energy electrons released during the TCA cycle. - These electrons are then transferred to the **electron transport chain (ETC)**, where their energy is used to pump protons and generate a **proton gradient**, ultimately driving **ATP synthesis** through **oxidative phosphorylation**. *They directly phosphorylate ADP to form ATP* - **NADH** and **FADH2** do not directly phosphorylate ADP; this process is characteristic of **substrate-level phosphorylation**, which occurs in steps of glycolysis and one step of the TCA cycle (succinyl CoA to succinate). - Instead, their energy is harnessed indirectly through the **electron transport chain** to power ATP synthase. *They act as substrates for gluconeogenesis* - While some TCA intermediates can be diverted for **gluconeogenesis**, **NADH** and **FADH2** themselves are not direct substrates for this pathway. - They are primarily involved in **energy production** rather than providing carbon skeletons for glucose synthesis. *They are used in the synthesis of fatty acids* - **NADPH**, a molecule structurally similar to NADH, is a key reductant in **fatty acid synthesis**, not NADH or FADH2. - While the TCA cycle provides precursors (like citrate) that can be used for fatty acid synthesis, **NADH** and **FADH2** are primarily involved in ATP generation.
Explanation: ***Glucose-6-phosphate dehydrogenase (G6PD) deficiency*** - G6PD deficiency leads to **decreased NADPH** production, impairing the reduction of **oxidized glutathione** and making red blood cells susceptible to **oxidative stress**. - **Heinz bodies** are formed when denatured hemoglobin precipitates within red blood cells due to oxidative damage, a **hallmark feature** of G6PD deficiency. - Common triggers include **oxidant drugs** (antimalarials, sulfonamides), **infections**, and **fava beans**. *Pyruvate kinase deficiency* - This deficiency affects the last step of **glycolysis**, reducing ATP production and leading to chronic **hemolytic anemia**. - It does not directly cause **oxidative stress** or the formation of **Heinz bodies**, as its primary impact is on red blood cell energy metabolism. - Presents with **echinocytes** (spiculated RBCs) rather than Heinz bodies. *Hexokinase deficiency* - A rare cause of **hemolytic anemia** that impairs the initial step of glycolysis, leading to reduced ATP production. - While it causes hemolysis, it is not associated with **oxidative stress** or **Heinz body** formation. - More commonly presents with **spherocytes** on blood smear. *Phosphoglycerate kinase deficiency* - This X-linked disorder affects an enzyme in the glycolytic pathway, leading to **hemolytic anemia** and sometimes neurologic symptoms. - It primarily impacts **ATP production** and does not directly relate to **oxidative damage** or **Heinz bodies**.
Explanation: ***Fatty acids*** - During a **prolonged fast**, the body shifts from utilizing glucose to **fatty acids** derived from stored triglycerides as its primary energy source. - While most tissues can directly use fatty acids for energy, the liver converts them into **ketone bodies** to provide fuel for the brain. *Glycogen* - **Glycogen stores** (primarily in the liver and muscles) are rapidly depleted within the first **24-48 hours** of fasting. - It serves as a short-term energy reserve and is not sufficient for prolonged fasting. *Amino acids* - **Amino acids** are primarily used for protein synthesis and can be converted to glucose via **gluconeogenesis** to maintain blood glucose, especially for glucose-dependent tissues like red blood cells. - Excessive use of amino acids for energy is detrimental as it leads to the breakdown of **muscle protein**. *Glucose* - **Glucose** is the primary energy source in the fed state and the initial phase of fasting. - During a prolonged fast, **glucose levels drop significantly**, and the body conserves its limited glucose for critical cellular functions, shifting to other primary energy sources.
Explanation: ***Pyruvate dehydrogenase deficiency*** - A mutation in the **pyruvate dehydrogenase (PDH) complex** directly impairs the conversion of pyruvate to acetyl-CoA, leading to a build-up of **pyruvate**. - Excess pyruvate is then shunted to lactate via **lactate dehydrogenase**, resulting in severe **lactic acidosis**. *Phenylketonuria* - This condition involves a deficiency in **phenylalanine hydroxylase**, leading to an accumulation of phenylalanine, not pyruvate or lactate. - Clinical features include developmental delay, seizures, and a musty odor, distinct from severe metabolic acidosis in a newborn. *Glycogen storage disease* - These disorders involve defects in **glycogen metabolism** and present with hypoglycemia, hepatomegaly, or muscle weakness depending on the specific type. - While some types can cause lactic acidosis, the primary defect is not in the PDH complex, and the clinical picture often involves **hypoglycemia** or **organ enlargement**. *Ornithine transcarbamylase deficiency* - This is an **X-linked urea cycle disorder** characterized by hyperammonemia, leading to neurological symptoms like lethargy, seizures, and coma. - It does not primarily present with severe lactic acidosis due to a defect in the PDH complex.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free